These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 15725082

  • 1. Low-grade primary central nervous system lymphoma in immunocompetent patients.
    Jahnke K, Thiel E, Schilling A, Herrlinger U, Weller M, Coupland SE, Krümpelmann U, Stein H, Korfel A.
    Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
    [Abstract] [Full Text] [Related]

  • 2. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [Abstract] [Full Text] [Related]

  • 3. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T.
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [Abstract] [Full Text] [Related]

  • 4. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
    Agarwal PA, Menon S, Smruti BK, Singhal BS.
    Neurol India; 2009 Sep; 57(6):756-63. PubMed ID: 20139505
    [Abstract] [Full Text] [Related]

  • 5. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
    Kawamura T, Koga S, Okamoto M, Kanno T, Iwamura H.
    Radiat Med; 2001 Sep; 19(3):145-9. PubMed ID: 11467381
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy.
    Sonoda Y, Matsumoto K, Kakuto Y, Nishino Y, Kumabe T, Tominaga T, Katakura R.
    Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511
    [Abstract] [Full Text] [Related]

  • 12. Primary central nervous system lymphomas: a 30-year experience at a single institution.
    Nuckols JD, Liu K, Burchette JL, McLendon RE, Traweek ST.
    Mod Pathol; 1999 Dec; 12(12):1167-73. PubMed ID: 10619271
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [T-type primary lymphoma of the central nervous system in immunocompetent patients].
    Barrena-Caballo MR, Blanch-Labrador M, Giménez-Mas JA, Alberdi-Viñas J, Pascual-Piazuelo M, Zubiri-Ara L.
    Rev Neurol; 1999 Dec; 36(2):125-30. PubMed ID: 12589598
    [Abstract] [Full Text] [Related]

  • 15. Primary central nervous system lymphoma.
    Ferreri AJ, Reni M.
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
    [Abstract] [Full Text] [Related]

  • 16. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
    Korfel A, Martus P, Nowrousian MR, Hossfeld DK, Kirchen H, Brücher J, Stelljes M, Birkmann J, Peschel C, Pasold R, Fischer L, Jahnke K, Thiel E, German primary central nervous system lymphoma Study Group (G-PCNSL-SG).
    Br J Haematol; 2005 Jan; 128(2):177-83. PubMed ID: 15638851
    [Abstract] [Full Text] [Related]

  • 17. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H, Takahashi H, Onda K, Takahashi H, Tanaka R.
    Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
    [Abstract] [Full Text] [Related]

  • 18. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
    Salvesen Haldorsen I, Aarseth JH, Hollender A, Larsen JL, Espeland A, Mella O.
    Acta Oncol; 2004 Jul; 43(6):520-9. PubMed ID: 15370608
    [Abstract] [Full Text] [Related]

  • 19. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P, Lemevel A, Bertrand P, Delwail V, Rachieru P, Brion A, Berthou C, Bay JO, Delepine R, Desablens B, Camilleri-Broët S, Linassier C, Lamy T.
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [Abstract] [Full Text] [Related]

  • 20. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K, Thiel E.
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.